Bou-Orm I R, Sakr R E, Adib S M
Department of epidemiology and population health, faculty of health sciences, American University of Beirut, P.O. Box 11-0236, 1107 2020 Riad El-Solh, Beirut, Lebanon.
Faculty of medicine, Saint-Joseph University, Beirut, Lebanon.
Rev Epidemiol Sante Publique. 2018 Feb;66(1):1-6. doi: 10.1016/j.respe.2017.10.004. Epub 2017 Dec 14.
Cervical cancer is a very common malignancy amongst women worldwide. Pap smear is an effective and inexpensive screening test in asymptomatic women. The aim of this paper was to assess the prevalence of Pap smear screening for cervical cancer among Lebanese women and to determine associated sociodemographic and psychosocial characteristics.
This national survey included 2255 women, selected by multi-stage random cluster sampling across Lebanon. A questionnaire about practices and perceptions related to cervical cancer screening was developed based on the "Health Belief Model".
The weighted national prevalence of "ever-use" of the Pap smear for screening purposes was 35%. Most important determinants of screening behavior were: residence within Greater Beirut, higher socio-economic status and educational attainment, marriage status, presence of a health coverage, awareness of Pap smear usefulness, knowing someone who had already done it, and a balance between perceived benefits and perceived barriers to Pap smear screening.
Regular information campaigns regarding the availability and effectiveness of the test should be devised, targeting in priority the sexually vulnerable women in Lebanon. Moreover, healthcare providers should be encouraged to discuss with their patients the opportunity of obtaining a Pap smear.
宫颈癌是全球女性中非常常见的恶性肿瘤。巴氏涂片检查是对无症状女性进行的一种有效且经济的筛查测试。本文的目的是评估黎巴嫩女性中宫颈癌巴氏涂片筛查的普及率,并确定相关的社会人口学和心理社会特征。
这项全国性调查包括2255名女性,通过在黎巴嫩全境进行多阶段随机整群抽样选取。基于“健康信念模型”制定了一份关于宫颈癌筛查的做法和认知的问卷。
用于筛查目的的巴氏涂片检查“曾经使用过”的加权全国普及率为35%。筛查行为的最重要决定因素包括:居住在大贝鲁特地区、较高的社会经济地位和教育程度、婚姻状况、有健康保险、知晓巴氏涂片检查的有用性、认识做过该检查的人,以及在巴氏涂片筛查的感知益处和感知障碍之间取得平衡。
应开展关于该检查的可及性和有效性的定期宣传活动,优先针对黎巴嫩性方面易受伤害的女性。此外,应鼓励医疗保健提供者与患者讨论进行巴氏涂片检查的机会。